Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Magdalena Kotlicka-Antczak
Affiliation
Medical University of Lodz
ORCID
Career Start Year
1997
Papers
49
H Index
17
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36832461
Affiliation to a Social Group as a Preventive Factor in Suicidal Behaviors in Children and Adolescents during the COVID-19 Pandemic.
Children (Basel)
2023
36360840
Are Children Harmed by Being Locked up at Home? The Impact of Isolation during the COVID-19 Pandemic on the Phenomenon of Domestic Violence.
Int J Environ Res Public Health
2022
35412635
3DLigandSite: structure-based prediction of protein-ligand binding sites.
Nucleic Acids Res
2022
35837472
The Orphan Response Regulator Rv3143 Modulates the Activity of the NADH Dehydrogenase Complex (Nuo) in <i>Mycobacterium tuberculosis via</i> Protein-Protein Interactions.
Front Cell Infect Microbiol
2022
35665763
Prognostic accuracy and clinical utility of psychometric instruments for individuals at clinical high-risk of psychosis: a systematic review and meta-analysis.
Mol Psychiatry
2022
36471745
Major Depression and Onset of Frontotemporal Dementia.
Neuropsychiatr Dis Treat
2022
33245168
Serum levels of neuropeptide Y in patients with chronic schizophrenia during treatment augmentation with sarcosine (results of the double-blind randomized controlled PULSAR study).
Hum Psychopharmacol
2021
33623384
The Relationship Between Antipsychotic Treatment and Plasma β-Endorphin Concentration in Patients with Schizophrenia.
Neuropsychiatr Dis Treat
2021
33560365
Differentially conserved amino acid positions may reflect differences in SARS-CoV-2 and SARS-CoV behaviour.
Bioinformatics
2021
32052573
Higher order language impairments can predict the transition of ultrahigh risk state to psychosis-An empirical study.
Early Interv Psychiatry
2021
32892205
Plasma β-Endorphin Concentration and Antipsychotic Treatment Outcome in Schizophrenia: 1-Year Follow-Up.
Med Sci Monit
2020
32067369
Worldwide implementation of clinical services for the prevention of psychosis: The IEPA early intervention in mental health survey.
Early Interv Psychiatry
2020
28857488
Preliminary study of higher-order language and extralinguistic impairments in individuals with high clinical risk of psychosis and first episode of schizophrenia.
Early Interv Psychiatry
2019
32099366
The Relationship Between Course of Illness and β-Endorphin Plasma Levels in Patients with Schizophrenia.
Neuropsychiatr Dis Treat
2019
31920732
Preventive Treatments for Psychosis: Umbrella Review (Just the Evidence).
Front Psychiatry
2019
31744546
The CAFA challenge reports improved protein function prediction and new functional annotations for hundreds of genes through experimental screens.
Genome Biol
2019
31178767
Individualized Prediction of Transition to Psychosis in 1,676 Individuals at Clinical High Risk: Development and Validation of a Multivariable Prediction Model Based on Individual Patient Data Meta-Analysis.
Front Psychiatry
2019
31308405
Environmental conditions shape the nature of a minimal bacterial genome.
Nat Commun
2019
30870626
Short clinically-based prediction model to forecast transition to psychosis in individuals at clinical high risk state.
Eur Psychiatry
2019
30831438
A developmentally-stable pattern of premorbid schizoid-schizotypal features predicts psychotic transition from the clinical high-risk for psychosis state.
Compr Psychiatry
2019
30880989
Odor perception and hedonics in chronic schizophrenia and in first episode psychosis.
Neuropsychiatr Dis Treat
2019
27111136
Polish individuals with an at-risk mental state: demographic and clinical characteristics.
Early Interv Psychiatry
2018
30510199
The NnaR orphan response regulator is essential for the utilization of nitrate and nitrite as sole nitrogen sources in mycobacteria.
Sci Rep
2018
28438437
Schizophrenia patients have higher-order language and extralinguistic impairments.
Schizophr Res
2018
29638031
Overrated hedonic judgment of odors in patients with schizophrenia.
CNS Neurosci Ther
2018
29413807
Meta-analytical prognostic accuracy of the Comprehensive Assessment of at Risk Mental States (CAARMS): The need for refined prediction.
Eur Psychiatry
2018
29117909
A history of obstetric complications is associated with the risk of progression from an at risk mental state to psychosis.
Schizophr Res
2018
27992836
Deconstructing vulnerability for psychosis: Meta-analysis of environmental risk factors for psychosis in subjects at ultra high-risk.
Eur Psychiatry
2017
26279283
Differences in omega-3 and omega-6 polyunsaturated fatty acid consumption in people at ultra-high risk of psychosis, first-episode schizophrenia, and in healthy controls.
Early Interv Psychiatry
2017
27765522
Deficits in the identification of pleasant odors predict the transition of an at-risk mental state to psychosis.
Schizophr Res
2017
26679763
A randomized controlled study of the efficacy of six-month supplementation with concentrated fish oil rich in omega-3 polyunsaturated fatty acids in first episode schizophrenia.
J Psychiatr Res
2016
27470411
Human toxoplasmosis-Searching for novel chemotherapeutics.
Biomed Pharmacother
2016
27154362
The association between polyunsaturated fatty acid consumption and the transition to psychosis in ultra-high risk individuals.
Prostaglandins Leukot Essent Fatty Acids
2016
24373200
Figural fluency and immediate visual memory in patients with at-risk mental state for psychosis: empirical study.
Early Interv Psychiatry
2015
26506383
Supplementation of Antipsychotic Treatment with the Amino Acid Sarcosine Influences Proton Magnetic Resonance Spectroscopy Parameters in Left Frontal White Matter in Patients with Schizophrenia.
Nutrients
2015
26501260
Adding Sarcosine to Antipsychotic Treatment in Patients with Stable Schizophrenia Changes the Concentrations of Neuronal and Glial Metabolites in the Left Dorsolateral Prefrontal Cortex.
Int J Mol Sci
2015
26501256
Comparison of Metabolite Concentrations in the Left Dorsolateral Prefrontal Cortex, the Left Frontal White Matter, and the Left Hippocampus in Patients in Stable Schizophrenia Treated with Antipsychotics with or without Antidepressants. ¹H-NMR Spectroscopy Study.
Int J Mol Sci
2015
26306650
Supplementation of antipsychotic treatment with sarcosine â¿¿ GlyT1 inhibitor â¿¿ causes changes of glutamatergic (1)NMR spectroscopy parameters in the left hippocampus in patients with stable schizophrenia.
Neurosci Lett
2015
26150720
Telomere length in blood cells is related to the chronicity, severity, and recurrence rate of schizophrenia.
Neuropsychiatr Dis Treat
2015
25934131
Omega-3 fatty acids in first-episode schizophrenia - a randomized controlled study of efficacy and relapse prevention (OFFER): rationale, design, and methods.
BMC Psychiatry
2015
25784808
Hypomania after augmenting venlafaxine and olanzapine with sarcosine in a patient with schizophrenia: a case study.
Neuropsychiatr Dis Treat
2015
24725353
PORT (Programme of Recognition and Therapy): the first Polish recognition and treatment programme for patients with an at-risk mental state.
Early Interv Psychiatry
2015
24157247
Obstetrical complications and Apgar score in subjects at risk of psychosis.
J Psychiatr Res
2014
25318035
Temperament traits and preference for surgical or nonsurgical specialties in year 6 medical students.
Teach Learn Med
2014
12955813
Suicidal ideation and suicide attempt in Polish adolescents: is it a suicidal process?
Int J Adolesc Med Health
2003
11578643
Obstetric complications and Apgar score in early-onset schizophrenic patients with prominent positive and prominent negative symptoms.
J Psychiatr Res
2001
11202017
[The role of obstetric complications in the pathogenesis of schizophrenia].
Psychiatr Pol
2000
10761437
[Clinical picture and duration of prodromal period of schizophrenia in adolescents].
Psychiatr Pol
1999
9547179
[Neurodevelopmental schizophrenia: the concept of developmental origins of certain forms of schizophrenia].
Psychiatr Pol
1997
1 - 49 of 49
Column Actions
Search
Recommended Authors
Cristiano Noto
Universidade Federal de Sao Paulo
Career Start Year
2011
Number of shared co-authors
0
Vanessa Kiyomi Ota
Departamento de Morfologia e Genetica - Universidade Federal de Sao Paulo (UNIFESP)
Career Start Year
2010
Number of shared co-authors
0
Ary Gadelha
Universidade Federal de Sao Paulo
Career Start Year
2009
Number of shared co-authors
0
Mirko Manchia
University of Cagliari
Career Start Year
2008
Number of shared co-authors
1
Sarah Kittel-Schneider
University Hospital Frankfurt am Main, University Hospital Wurzburg
Career Start Year
2007
Number of shared co-authors
1
Sintia Iole Belangero
National Institute of Developmental Psychiatry for Children and Adolescents (INPD)
Career Start Year
2006
Number of shared co-authors
0
Xin Yu
Peking University Sixth Hospital, Peking University Institute of Mental Health
Career Start Year
2004
Number of shared co-authors
0
Sarah E Bergen
Karolinska Institutet
Career Start Year
2004
Number of shared co-authors
2
Elisabetta C Del Re
Harvard Medical School VA Boston HealthCare System.
Career Start Year
2004
Number of shared co-authors
0
Evangelos Vassos
Institute of Psychiatry, King's College London
Career Start Year
2002
Number of shared co-authors
0
Rodrigo A Bressan
Universidade Federal de Sao Paulo (UNIFESP), Brazil Instituto #amesuamente.
Career Start Year
1998
Number of shared co-authors
0
Thomas G Schulze
SUNY Upstate Medical University
Career Start Year
1998
Number of shared co-authors
1
Andreas Reif
University Hospital Frankfurt am Main
Career Start Year
1998
Number of shared co-authors
1
Adrian Preda
University of California Irvine
Career Start Year
1998
Number of shared co-authors
0
Mikael Land??n
Karolinska Institutet
Career Start Year
1996
Number of shared co-authors
2
Ole A Andreassen
Oslo University Hospital & Institute of Clinical Medicine, University of Oslo
Career Start Year
1994
Number of shared co-authors
1
Jean-Michel Aubry
Geneva University Hospitals.
Career Start Year
1993
Number of shared co-authors
1
Christina M Hultman
Karolinska Institutet
Career Start Year
1992
Number of shared co-authors
1
Urban ??sby
Karolinska Institutet
Career Start Year
1992
Number of shared co-authors
1
Ingrid Melle
University of Oslo
Career Start Year
1991
Number of shared co-authors
1
Alfonso Tortorella
University of Perugia
Career Start Year
1991
Number of shared co-authors
1
Irismar Reis de Oliveira
Institute of Health Sciences, Federal University of Bahia
Career Start Year
1990
Number of shared co-authors
0
Jon McClellan
University of Washington
Career Start Year
1988
Number of shared co-authors
0
Peter Falkai
Ludwig-Maximilians-Universitat Munchen.
Career Start Year
1986
Number of shared co-authors
1
Jean-Pierre Kahn
Department of Psychiatry and Clinical Psychology
Career Start Year
1982
Number of shared co-authors
1
Marion Leboyer
INSERM U
Career Start Year
1982
Number of shared co-authors
1
Mario Maj
University of Campania Luigi Vanvitelli
Career Start Year
1979
Number of shared co-authors
1
Wolfgang Maier
University Hospital Bonn
Career Start Year
1972
Number of shared co-authors
1
Dilip V Jeste
Neurosciences University of California San Diego
Career Start Year
1969
Number of shared co-authors
0
Ming T Tsuang
University of California San Diego
Career Start Year
1961
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Mark N Wass
University of Kent
Co-authored papers
4
Naihui Zhou
The First Affiliated Hospital of Soochow University
Co-authored papers
1
Devon Johnson
Pacific Lutheran University
Co-authored papers
1
Peter L Freddolino
University of Michigan ann arbor
Co-authored papers
1
Prajwal Bhat
Royal Holloway University of London
Co-authored papers
1
Itamar Borukhov
Institute of Biotechnology, University of Helsinki
Co-authored papers
1
Maria J Martin
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers
1
Md Nafiz Hamid
Iowa State University
Co-authored papers
1
Larry Davis
Co-authored papers
1
Radoslav Davidovic
Institute of Nuclear Sciences Vinca, University of Belgrade
Co-authored papers
1
Mohammad R K Mofrad
University of California Berkeley
Co-authored papers
1
Sa??o D??eroski
Jozef Stefan Institute
Co-authored papers
1
Domenico Cozzetto
Imperial College London
Co-authored papers
1
Marco Mesiti
Universita degli Studi di Milano
Co-authored papers
1
Neven Sumonja
Institute of Nuclear Sciences VINCA, University of Belgrade
Co-authored papers
1
Alan J Medlar
Co-authored papers
1
Rui Fa
University College London
Co-authored papers
1
Sabeur Aridhi
Universite de Lorraine, CNRS
Co-authored papers
1
Qizhong Mao
Temple University
Co-authored papers
1
Fabio Fabris
University of Kent
Co-authored papers
1
Wei-Cheng Tseng
Taipei Veterans General Hospital
Co-authored papers
1
Christophe Dessimoz
University of Lausanne
Co-authored papers
1
Gage S Black
Brigham Young University
Co-authored papers
1
Suyang Dai
Fudan University
Co-authored papers
1
Maxat Kulmanov
King Abdullah University of Science and Technology.
Co-authored papers
1
Kai Hakala
University of Turku
Co-authored papers
1
Tomislav ??muc
Ruder Boskovic Institute
Co-authored papers
1
Giuseppe Profiti
University of Bologna
Co-authored papers
1
Olivier Lichtarge
Baylor College of Medicine
Co-authored papers
1
Constance J Jeffery
University of Illinois at Chicago
Co-authored papers
1
1 - 30